The financials
agilon health, inc. by the numbers
agilon health, inc. (AGL) reported revenue of $1.42B in Q1 2026 (quarter ended March 31, 2026), down 7.3% from the same quarter a year earlier. That came with net income of $49M (3.4% of revenue). For the full year FY2025, revenue was $5.93B (−2.1% year on year) and net income −$391M. Its largest product in 2026-Q1 was Medical Services at $1.42B, 100% of the disclosed total, just ahead of Other Operating at 0.1%.
| Income statement | Q1 2026 | Q1 2025 | Change |
|---|---|---|---|
| Revenue | $1.42B | $1.53B | −7.3% |
| Operating income | $4.0M | −$22M | to a profit |
| Net income | $49M | $12M | +304% |
| Diluted EPS | $2.94 | $0.73 | +303% |
| Product | Revenue | Share |
|---|---|---|
| Medical Services | $1.42B | 100% |
| Other Operating | $1.9M | 0.1% |
Business Segments
Revenue split by product segment, from SEC XBRL filings.
Latest period: Q1 2026Total $1.42B (-1.0%)
Medical Services grew -7.3% year on yearOther Operating -34% year on year
Segment Latestquarter on quarteryear on year
- Medical Services$1.42B$1.42BQoQ -0.97%year on year -7.3%-0.97%-7.3%
- Other Operating$1.9M$1.9MQoQ -34%year on year -34%-34%-34%